Unusual Call-Option Volume
Unusual Call-Option Activity Surges Across Four Notable Stocks Amid Mixed Earnings
Anonymous
Key Points
1
Gilead Sciences reported adjusted quarterly earnings of negative $6.75 per share, beating the consensus estimate of negative $7.25, while revenue rose 10.6% year over year to $7.80 billion from $7.40 billion expected.
2
On Holding’s shares were trading at $27.48, close to their 12-month low of $26.60 and well below the 12-month high of $51.08; the company’s debt-to-equity ratio was 0.25 and current ratio was 2.83.
3
CG Oncology exceeded revenue expectations despite missing its earnings estimate, reporting $1.16 million in quarterly revenue versus the $0.36 million consensus forecast, while posting a loss of $0.90 per share compared with the expected loss of $0.66.
4
CG Oncology’s analyst coverage was broadly positive but not unanimous: nine analysts rated the stock Buy, one rated it Hold and one rated it Sell, producing a consensus Moderate Buy rating and an average price target of $87.78.
5
American Resources recently paid a dividend of $0.0431 per share to shareholders of record on Aug. 15, with the distribution made on Aug. 25.
Four stocks saw unusual surges in call-option trading this week, signaling investors are betting on sharp price moves. Yahoo Finance data showed CG Oncology's call volume jumped 642% above normal, On Holding's climbed 175%, Gilead Sciences' rose 54%, and American Resources' increased 35%. The activity followed mixed earnings reports and corporate actions, creating a disconnect between traditional market pessimism and options-trader optimism.
Gilead Beats Revenue Forecast, Attracts Call Buyers
Gilead Sciences delivered stronger-than-expected quarterly results, pushing shares higher during the trading day. The pharmaceutical company reported adjusted earnings of negative $6.75 per share, beating the consensus estimate of negative $7.25. Revenue climbed 10.6% year over year to $7.80 billion, surpassing the $7.40 billion forecast. The earnings beat sparked a 54% jump in call-option purchases above typical daily volume, according to Yahoo Finance.
On Holding Trades Near Year Low Despite Call Surge
On Holding shares hit near their 12-month bottom despite attracting heavy call buying. The footwear maker traded at $27.48, just above its 12-month low of $26.60, after missing earnings and revenue estimates. Yet call-option volume jumped 175% above normal, Ticker Report data shows. The company's strong balance sheet—a debt-to-equity ratio of 0.25 and current ratio of 2.83—suggests traders see this as a buying opportunity despite near-term headwinds.
CG Oncology Faces Largest Options Spike Despite Loss
CG Oncology experienced the sharpest call-option surge: 642% above typical volume. The clinical-stage oncology company beat revenue expectations with $1.16 million in quarterly sales versus the $0.36 million consensus forecast. However, it posted a per-share loss of $0.90, worse than the expected loss of $0.66. Despite the earnings miss, nine analysts maintain Buy ratings, one says Hold, and one rates it Sell—producing a consensus Moderate Buy with a $87.78 average price target, Ticker Report reported.
American Resources Pays Dividend, Draws Modest Call Interest
American Resources paid a dividend of $0.0431 per share on August 25 to shareholders of record as of August 15. The distribution triggered a 35% spike in call-option volume above normal levels. Wall Street maintains a consensus Moderate Buy rating despite a Sell rating from Weiss Ratings. The small-cap natural-resources firm's options activity suggests market participants are cautiously positioning for upside moves.
Sentiment
Mostly PositiveNEGATIVENEUTRALPOSITIVE
Publishers
54
Articles
83
Reach
137
A
AnonymousAuthor
